Blood test to monitor tuberculosis treatment
Part of Infections, Lungs & breathing clinical trials.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with tuberculosis (confirmed by a lab test).
- You have not started tuberculosis treatment yet.
- You have not taken tuberculosis medication in the last 8 weeks.
- You have no history of cancer, are not pregnant, and do not have transfusion-dependent anemia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new finger-prick blood test (PATHFAST-LAM) to see if it can help doctors monitor how well tuberculosis (TB) treatment is working. It is for adults who are newly diagnosed with TB and have not yet started medication.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
This trial checks if a blood test can find TB DNA before a lung procedure called bronchoscopy. It may help people who need a bronchoscopy but cannot cough up sputum for testing.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
Hear when a new Mycobacterium Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.